For laboratory and research use only. Not for human or animal consumption. Sold to qualified researchers and licensed laboratories.
HomeShopPeptide Blends › CJC-1295 (no DAC) + GHRP-6
CJC-1295 (no DAC) + GHRP-6 5/5 mg research peptide vial with lot CJC-2609-Y label
Peptide Blends · SKU CGB-5-5

CJC-1295 (no DAC) + GHRP-6 5/5 mg

GHRH analogue paired with a ghrelin-receptor secretagogue.

$ 85 per 5/5 mg vial · free shipping over $300

In stock · ships same day on orders before 2pm ET

Purity (HPLC-UV)≥99.0% on lot CJC-2609-Y
IdentityConfirmed by LC-MS
FormLyophilized powder, sealed vial
Endotoxin< 0.5 EU/mg (LAL)
Storage-20°C sealed · 2-8°C reconstituted
Volume pricing, applied automatically in the cart
QuantityPer unitYou save
3 to 4 units$79.057%
5 to 9 units$75.6511%
10+ units$71.4016%

Verify lot CJC-2609-Y in the COA library · This month's lot report

Ships same day on orders before 2pm ET. For laboratory research use only. Not for human or animal consumption.

Frequently bought together

Supplies researchers add to this order

Reconstitution kit
Reconstitution kitKit · $49.99

What is CJC-1295 (no DAC) + GHRP-6?

This blend pairs CJC-1295 without DAC, a GHRH analogue, with GHRP-6, a ghrelin receptor agonist, in one lot-matched vial. The two act on separate receptors in the same axis, which is the reason for pairing them. Pepstral supplies it as a lyophilized powder for in-vitro laboratory research only.

What is CJC-1295 (no DAC) + GHRP-6 studied for?

  • Dual-receptor growth hormone axis studies
  • GHRH and ghrelin receptor interaction research
  • Pulsatile release models
  • Combination versus single-compound comparisons

All applications above are in-vitro or preclinical research contexts. CJC-1295 (no DAC) + GHRP-6 is sold for laboratory research only and is not for human or animal use.

What does the certificate for lot CJC-2609-Y show?

Every lot of CJC-1295 (no DAC) + GHRP-6 is tested by an independent US laboratory before it is listed. The report for lot CJC-2609-Y is in the COA library and the lot number printed on the vial matches it. The current results:

TestMethodLot CJC-2609-Y result
IdentityLC-MSMatches the calculated mass for the sequence
PurityHPLC-UV, 220 nm99.0%
Net peptide contentAmino acid analysisStated per vial on the certificate
EndotoxinLAL, chromogenic< 0.5 EU/mg
SterilityUSP <71>Pass

How is CJC-1295 (no DAC) + GHRP-6 handled and stored?

Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within the 28-day window on the certificate. The reconstitution guide covers volumes and syringe units and the concentration table gives the numbers for this vial.

Frequently asked questions

Why pair a GHRH analogue with a secretagogue?

They engage different receptors on the same pathway, so a combination separates additive from independent effects.

Is the CJC component the DAC form?

No. This blend uses the no-DAC form, which clears in minutes rather than days.

Is CJC-1295 (no DAC) + GHRP-6 for human use?

No. Every product on this site is sold for in-vitro laboratory research only and is not for human or animal consumption, diagnostic or therapeutic use.

Related

More in Peptide Blends

Blend
BPC-157 + TB-500 10 mg blend research peptide vial

BPC-157 + TB-500

Peptide Blends · 10 mg blend
≥99.1% purity · COA lot BL-2609-B
from$108
Blend
CJC-1295 + Ipamorelin 5/5 mg research peptide vial

CJC-1295 + Ipamorelin

Peptide Blends · 5/5 mg
≥99.0% purity · COA lot BL-2608-E
from$90
KLOW blend 80 mg blend research peptide vial

KLOW blend

Peptide Blends · 80 mg blend
≥99.0% purity · COA lot KLO-2609-X
from$200
COA on every lotPublished before listing
≥99% purityHPLC and LC-MS verified
Same-day shippingOrders before 2pm ET
Secure checkout256-bit encrypted
USA-basedSynthesized and shipped domestically
Discreet packagingPlain box, no product names

Restock alerts and new lot reports, by email

One email when a new certificate is published, when a sold-out compound is back, or when a new compound is added. About twice a month, nothing else.